Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|June 27, 2015
Everolimus for the treatment of lymphangioleiomyomatosis: a phase II studyHilary J Goldberg, Sergio Harari, Vincent Cottin, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2014
Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidatesMiae Kim, Keri R Townsend, Isabelle G Wood, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 23, 2017
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunctionAnna Moniodis, Keri Townsend, Alexander Rabin, et al.
Scientific Reports|June 23, 2019
Hyaluronan and LYVE-1 and allograft function in lung transplantation recipientsAndrew M Courtwright, Anthony M Lamattina, Pierce H Louis, et al.
Orphanet Journal of Rare Diseases|March 30, 2019
Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosisAnthony M Lamattina, Sergio Poli, Pranav Kidambi, et al.
The Annals of Thoracic Surgery|December 11, 2017
Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant RecipientsAndrew M Courtwright, Patrick Burkett, Miguel Divo, et al.
Advances in Therapy|September 14, 2019
The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJoshua J Solomon, Sonye K Danoff, Hilary J Goldberg, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Characterization of lymphangioleiomyomatosis patients with discordance between spirometric and diffusion measurements of pulmonary functionAndrew M Courtwright, Bruno G Baldi, Pranav Kidambi, et al.
Transplantation|November 29, 2016
The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related DeathOscar E Zazueta, Sara E Preston, Anna Moniodis, et al.
JHLT Open|March 27, 2025
Iatrogenic esophageal dysmotility as a barrier to transplantation in pulmonary arterial hypertensionMichael S Miller, Shelsey W Johnson, Alexander R Opotowsky, et al.
Pageof 9